[Disordered repair processes in patients with gouty nephropathy]

Area of Science:

• Immunology
• Nephrology
• Genetics

Background:

• Lymphocyte DNA repair synthesis is crucial for cellular health.
• Kidney diseases like gout and nephritis, and autoimmune conditions like systemic lupus erythematosus, can impact cellular function.
• Hyperuricemia and hyperuricosuria are associated with renal involvement and metabolic disturbances.

Purpose of the Study:

• To assess DNA repair activity in lymphocytes of patients with primary gout, chronic nephritis, and systemic lupus erythematosus.
• To investigate the correlation between DNA repair synthesis inhibition and disease severity or renal function.
• To explore the potential of DNA repair activity as a premorbid diagnostic criterion.

Main Methods:

• Utilized the DNA reparative synthesis test to measure lymphocyte DNA repair activity.
• Assessed 18 patients: 10 with primary gout (renal involvement), 6 with chronic nephritis (hyperuricemia), 1 with hyperuricosuria, and 1 with systemic lupus erythematosus.
• Analyzed the degree of DNA synthesis inhibition in relation to uricemia and renal function.

Main Results:

• Significant inhibition of DNA reparative synthesis was observed in 15 out of 18 patients (83%).
• Deep inhibition occurred in 11 patients, and partial inhibition in 4 patients.
• The extent of DNA synthesis inhibition did not correlate with renal function or serum uricemia levels.

Conclusions:

• Lymphocyte DNA reparative synthesis is frequently impaired in patients with kidney and autoimmune diseases.
• DNA repair activity shows potential as a sensitive biomarker for early disease detection, possibly at the premorbid stage.
• Further research is warranted to validate DNA repair synthesis as a clinical criterion for disease development.